Background: Lymphatic filariasis (LF) is gruesome disease which is endemic in many countries, with more than a billion people at risk of infection. In view with the global elimination, mass drug administration (MDA) with single dose of diethylcarbamazine tablets was carried out for the eligible population in Bidar district.
Aims & Objective: This study was undertaken to assess coverage of MDA against Lymphatic Filariasis in Bidar district.
Material and Methods: A cross-sectional coverage evaluation survey in one urban and three rural clusters were selected randomly in Bidar district. The data were collected in a pretested interview performa, computed and analyzed using SPSS-12.0 to calculate frequencies and proportions.
Results: A total of four clusters in the districts resulted in a study population of 642 individuals. The overall compliance rate in Bidar district was 52.18%. The prime reason for noncompliance was fear of side effects, not received tablets and not present at home.
Conclusion: There is an urgent need for more effective drug delivery strategies to improve the compliance in the district.
Key words: Mass Drug Administration, Lymphatic Filariasis, Diethylcarbamazine
|
